Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (211-220 of 685) with videos related to

Pageof 69
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancerSao Jiralerspong, Shana L Palla, Sharon H Giordano, et al.
Cancer|May 25, 2005
Improving local control with breast-conserving therapy: a 27-year single-institution experienceNeslihan Cabioglu, Kelly K Hunt, Thomas A Buchholz, et al.
Cancer|October 13, 2007
Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomyJudy C Boughey, Janice N Cormier, Yan Xing, et al.
JCO Precision Oncology|October 31, 2022
Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With <i>ERBB2</i> Amplification or <i>ERBB2/3</i> Mutations: Results From the TAPUR StudyRanju Gupta, Funda Meric-Bernstam, Michael Rothe, et al.
Breast Cancer Research and Treatment|December 5, 2012
High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patientsAshley M Holder, Ana M Gonzalez-Angulo, Huiqin Chen, et al.
Oncotarget|November 20, 2019
Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm studySarina A Piha-Paul, Matthew H Taylor, Daniel Spitz, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2009
High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancersBanu Arun, Kristen J Vogel, Adriana Lopez, et al.
American Journal of Surgery|September 17, 2005
Determinants of mastectomy in breast conservation therapy candidatesWaddah Al-Refaie, Henry M Kuerer, Alam Khuwaja, et al.
Cancer|September 29, 2011
Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancerSoley Bayraktar, Ana M Gonzalez-Angulo, Xiudong Lei, et al.
Cancer|February 11, 2009
The impact of pregnancy on breast cancer outcomes in women<or=35 yearsBeth M Beadle, Wendy A Woodward, Lavinia P Middleton, et al.
Pageof 69

Showing results (211-220 of 685) with videos related to

Sort By:
Pageof 69
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancerSao Jiralerspong, Shana L Palla, Sharon H Giordano, et al.
Cancer|May 25, 2005
Improving local control with breast-conserving therapy: a 27-year single-institution experienceNeslihan Cabioglu, Kelly K Hunt, Thomas A Buchholz, et al.
Cancer|October 13, 2007
Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomyJudy C Boughey, Janice N Cormier, Yan Xing, et al.
JCO Precision Oncology|October 31, 2022
Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With <i>ERBB2</i> Amplification or <i>ERBB2/3</i> Mutations: Results From the TAPUR StudyRanju Gupta, Funda Meric-Bernstam, Michael Rothe, et al.
Breast Cancer Research and Treatment|December 5, 2012
High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patientsAshley M Holder, Ana M Gonzalez-Angulo, Huiqin Chen, et al.
Oncotarget|November 20, 2019
Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm studySarina A Piha-Paul, Matthew H Taylor, Daniel Spitz, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2009
High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancersBanu Arun, Kristen J Vogel, Adriana Lopez, et al.
American Journal of Surgery|September 17, 2005
Determinants of mastectomy in breast conservation therapy candidatesWaddah Al-Refaie, Henry M Kuerer, Alam Khuwaja, et al.
Cancer|September 29, 2011
Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancerSoley Bayraktar, Ana M Gonzalez-Angulo, Xiudong Lei, et al.
Cancer|February 11, 2009
The impact of pregnancy on breast cancer outcomes in women<or=35 yearsBeth M Beadle, Wendy A Woodward, Lavinia P Middleton, et al.
Pageof 69